Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Dellapasqua
Silvia
S
Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
Colleoni
Marco
M
Gelber
Richard D
RD
Goldhirsch
Aron
A
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D017115:Catheter Ablation / Q000379:methods*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008875:Middle Aged; D010052:Ovariectomy; D010053:Ovary / Q000187:drug effects* / Q000502:physiology / Q000601:surgery; D017697:Premenopause; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D015996:Survival Rate; D013629:Tamoxifen / Q000627:therapeutic use*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen